22.03.2013 Views

et al.

et al.

et al.

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

precision and efficiency. To investigate the specificity<br />

of RNA-guided genome modification,<br />

we an<strong>al</strong>yzed single-nucleotide mismatches b<strong>et</strong>ween<br />

the spacer and its mamm<strong>al</strong>ian protospacer<br />

targ<strong>et</strong> (Fig. 3A). We observed that single-base<br />

mismatch up to 11 bp 5′ of the PAM compl<strong>et</strong>ely<br />

abolished genomic cleavage by SpCas9, whereas<br />

spacers with mutations farther upstream r<strong>et</strong>ained<br />

activity against the protospacer targ<strong>et</strong> (Fig. 3B).<br />

A<br />

B<br />

human<br />

EMX1<br />

locus<br />

pre-crRNA<br />

tracrRNA<br />

protospacer (1)<br />

pre-crRNA + tracrRNA processing<br />

spacer (30 bp)<br />

chimeric RNA<br />

guide sequence (20 bp)<br />

Fig. 2. SpCas9 can be reprogrammed to targ<strong>et</strong> multiple genomic loci in<br />

mamm<strong>al</strong>ian cells. (A) Schematic of the human EMX1 locus showing the<br />

location of five protospacers indicated by blue lines with corresponding<br />

PAM in magenta. (B) Schematic of the pre-crRNA:tracrRNA complex (top)<br />

showing hybridization b<strong>et</strong>ween the direct repeat (gray) region of the precrRNA<br />

and tracrRNA. Schematic of a chimeric RNA design (12) (bottom).<br />

A<br />

human EMX1<br />

locus<br />

C<br />

wt crRNA<br />

mismatchcontaining<br />

guide<br />

sequences<br />

human<br />

EMX1<br />

locus<br />

left TALEN binding site<br />

protospacer (1)<br />

protospacer (1)<br />

This is consistent with previous bacteri<strong>al</strong> and in<br />

vitro studies of Cas9 specificity (12, 20). Furthermore,<br />

SpCas9 is able to mediate genomic cleavage<br />

as efficiently as a pair of TALE nucleases<br />

(TALENs) targ<strong>et</strong>ing the same EMX1 protospacer<br />

(Fig.3,CandD).<br />

Targ<strong>et</strong>ed modification of genomes ide<strong>al</strong>ly<br />

avoids mutations arising from the error-prone<br />

NHEJ mechanism. The wild-type SpCas9 is able<br />

PAM<br />

PAM<br />

right TALEN binding site<br />

Fig. 3. Ev<strong>al</strong>uation of the SpCas9 specificity and comparison of efficiency<br />

with TALENs. (A) EMX1-targ<strong>et</strong>ing chimeric crRNAs with single point mutations<br />

were generated to ev<strong>al</strong>uate the effects of spacer-protospacer mismatches. (B)<br />

protospacer (5)<br />

C EMX1<br />

protospacer<br />

targ<strong>et</strong><br />

to mediate site-specific DSBs, which can be repaired<br />

through either NHEJ or homology-directed<br />

repair (HDR). We engineered an aspartate-to<strong>al</strong>anine<br />

substitution (D10A) in the RuvC I domain<br />

of SpCas9 to convert the nuclease into a<br />

DNA nickase (SpCas9n, Fig. 4A) (12, 13, 20),<br />

because nicked genomic DNA is typic<strong>al</strong>ly repaired<br />

either seamlessly or through high-fidelity<br />

HDR. SURVEYOR (Fig. 4B) and sequencing of<br />

protospacer (4)<br />

protospacer (2)<br />

protospacer (3)<br />

tracrRNA sequence is shown in red and the 20-bp spacer sequence in<br />

blue. (C) SURVEYOR assay comparing the efficacy of Cas9-mediated<br />

cleavage at five protospacers in the human EMX1 locus. Each protospacer<br />

was targ<strong>et</strong>ed by using either processed pre-crRNA:tracrRNA complex (crRNA)<br />

or chimeric RNA (chiRNA). Arrowheads indicate cleavage products for<br />

each protospacer targ<strong>et</strong>.<br />

B<br />

684bp<br />

367bp<br />

317bp<br />

indel (%)<br />

indel (%)<br />

chimeric RNA with mismatched guide sequence<br />

2kb<br />

m17<br />

m15<br />

m13<br />

m11<br />

m9<br />

m7<br />

m5<br />

m4<br />

m3<br />

m2<br />

m1<br />

wt<br />

5.6 7.5 8.8 9.7<br />

D TALEN chimeric RNA crRNA control<br />

684bp<br />

367bp<br />

317bp<br />

3.6 3.8 4.5 11 7.4 8.6 22 29 25<br />

REPORTS<br />

SURVEYOR assay comparing the cleavage efficiency of different mutant chimeric<br />

RNAs. (C) Schematic showing the design of TALENs that targ<strong>et</strong> EMX1.<br />

(D) SURVEYOR gel comparing the efficiency of TALEN and SpCas9 (N =3).<br />

www.sciencemag.org SCIENCE VOL 339 15 FEBRUARY 2013 821<br />

on February 14, 2013<br />

www.sciencemag.org<br />

Downloaded from

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!